513 related articles for article (PubMed ID: 30514193)
41. Pleuroscopic Pleurodesis Combined With Tunneled Pleural Catheter for Management of Malignant Pleural Effusion: A Prospective Observational Study.
Boujaoude Z; Bartter T; Abboud M; Pratter M; Abouzgheib W
J Bronchology Interv Pulmonol; 2015 Jul; 22(3):237-43. PubMed ID: 26165894
[TBL] [Abstract][Full Text] [Related]
42. [Complications of malignant tumors--malignant pleural effusions].
Eggeling S; Kaiser D
MMW Fortschr Med; 2004 May; 146(21):40-2. PubMed ID: 15373083
[TBL] [Abstract][Full Text] [Related]
43. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
44. Treatment of malignant pleural effusions.
Erasmus JJ; Patz EF
Curr Opin Pulm Med; 1999 Jul; 5(4):250-5. PubMed ID: 10407696
[TBL] [Abstract][Full Text] [Related]
45. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting.
Petrou M; Kaplan D; Goldstraw P
Cancer; 1995 Feb; 75(3):801-5. PubMed ID: 7530167
[TBL] [Abstract][Full Text] [Related]
46. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
[TBL] [Abstract][Full Text] [Related]
47. The treatment of pleural carcinosis with malignant pleural effusion.
Ried M; Hofmann HS
Dtsch Arztebl Int; 2013 May; 110(18):313-8. PubMed ID: 23720697
[TBL] [Abstract][Full Text] [Related]
48. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
Korsic M; Badovinac S; Cucevic B; Janevski Z
Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
[TBL] [Abstract][Full Text] [Related]
49. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention.
Marrazzo A; Noto A; Casà L; Taormina P; Lo Gerfo D; David M; Mercadante S
J Pain Symptom Manage; 2005 Jul; 30(1):75-9. PubMed ID: 16043010
[TBL] [Abstract][Full Text] [Related]
50. ERS/EACTS statement on the management of malignant pleural effusions.
Bibby AC; Dorn P; Psallidas I; Porcel JM; Janssen J; Froudarakis M; Subotic D; Astoul P; Licht P; Schmid R; Scherpereel A; Rahman NM; Cardillo G; Maskell NA
Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 30054348
[TBL] [Abstract][Full Text] [Related]
51. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for pleural effusion recurrence in patients with malignancy.
Grosu HB; Molina S; Casal R; Song J; Li L; Diaz-Mendoza J; Reddy C; Yarmus L; Schiavo D; Simoff M; Johnstun J; Raid AA; Feller-Kopman D; Lee H; Sahetya S; Foley F; Maldonado F; Tian X; Noor L; Miller R; Mudambi L; Saettele T; Vial-Rodriguez M; Eapen GA; Ost DE
Respirology; 2019 Jan; 24(1):76-82. PubMed ID: 29966171
[TBL] [Abstract][Full Text] [Related]
53. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
54. Management of malignant pleural effusions.
Uzbeck MH; Almeida FA; Sarkiss MG; Morice RC; Jimenez CA; Eapen GA; Kennedy MP
Adv Ther; 2010 Jun; 27(6):334-47. PubMed ID: 20544327
[TBL] [Abstract][Full Text] [Related]
55. What is the best treatment for malignant pleural effusions?
Zahid I; Routledge T; Billè A; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):818-23. PubMed ID: 21325469
[TBL] [Abstract][Full Text] [Related]
56. Management of malignant pleural effusion.
Chen H; Brahmer J
Curr Oncol Rep; 2008 Jul; 10(4):287-93. PubMed ID: 18778553
[TBL] [Abstract][Full Text] [Related]
57. [Malignant pleural effusion].
Fjællegaard K; Petersen JK; Armbruster K; Jensen HK; Skaarup SH; Laursen CB; Clementsen PF; Bødtger U
Ugeskr Laeger; 2021 Apr; 183(17):. PubMed ID: 33913425
[TBL] [Abstract][Full Text] [Related]
58. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.
Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K
Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395
[TBL] [Abstract][Full Text] [Related]
59. Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis.
Wong WM; Tam TC; Wong MK; Lui MM; Ip MS; Lam DC
Hong Kong Med J; 2016 Aug; 22(4):334-40. PubMed ID: 27256467
[TBL] [Abstract][Full Text] [Related]
60. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway.
Ahmed L; Ip H; Rao D; Patel N; Noorzad F
Chest; 2014 Dec; 146(6):e190-e194. PubMed ID: 25451360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
